Actions
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
2
Neutral
5
Bullish
7
Bearish
30
Neutral
5
Bullish
11
Bearish
28
Neutral
0
Bullish
4
Bearish
2
Neutral
5
Bullish
7
Bearish
2
Neutral
5
Bullish
7
Bearish
28
Neutral
0
Bullish
4
Bearish
28
Neutral
0
Bullish
4
Bearish
28
Neutral
0
Bullish
4
Commercial Services & Supplies
Trading & Distributors
473 Cr
Low Risk
32.4
20.5
1.7
0.3
861.95
405.00
Sales CAGR
Profit CAGR
ROE
ROCE
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Riddhi Siddhi Gluco Biols Ltd (RIDDHI) is currently trading at 668.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Riddhi Siddhi Gluco Biols Limited is a diversified public company engaged primarily in wind power generation and trading of agricultural and metal commodity items, with recent operations expanding into packaged water bottling and a re-entry into starch manufacturing after acquiring Cargill’s starch division assets in April 2026. The company reported standalone total income of Rs. 10,493.27 lakhs and profit before tax of Rs. 1,548.95 lakhs for the quarter ended June 30, 2026, supported by substantial unallocable investment income; consolidated continuing operations produced operating profit before tax of Rs. 581.50 lakhs, illustrating mixed segment-level performance. In 2026 Riddhi Siddhi Gluco Biols Limited completed a material Asset Purchase Agreement with Cargill and acquired a 26% interest in Clean Max Pluto Solar Power LLP (operating a 25.30 MW wind and solar plant), signalling strategic re-entry into manufacturing and ownership of utility-scale renewable capacity. Corporate actions in Q1 FY2027 included achieving Minimum Public Shareholding by divestment via Offer for Sale, which reduced promoter and promoter-group holding to 75%, and the company disclosed ongoing regulatory approvals, a tax contingency appeal, and a six-month promoter restraint period ending December 23, 2026. Consolidated results reflect legacy challenges at the subsidiary: discontinued paper division impairments of Rs. 2,784.33 lakhs and continuing asset disposals, while the parent’s OCI included large equity instrument gains that materially affected total comprehensive income for the quarter.
Over the past 52 weeks, Riddhi Siddhi Gluco Biols Ltd has traded between a low of ₹405.00 and a high of ₹861.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Riddhi Siddhi Gluco Biols Ltd has a market capitalization of approximately 473.28. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Riddhi Siddhi Gluco Biols Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 32.37 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 473.28 Cr, Riddhi Siddhi Gluco Biols Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Riddhi Siddhi Gluco Biols Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Riddhi Siddhi Gluco Biols Ltd is 32.37. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The company reported a FY26 standalone net profit of ₹56.31 crore (₹5,630.56 lakh), down from ₹94.12 crore (₹9,411.91 lakh) in the previous year.
